Smart Investing Blog2023-06-05T18:48:08+00:00
310, 2024

Chevron, ExxonMobil, and Other Energy Stocks are Climbing on Middle East Conflict: Is it Time to Buy?

By |October 3rd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

It’s like clockwork. Anytime there’s tension in the Middle East it poses a threat to the world’s oil supply, and prices surge accordingly. That’s what we’re seeing this morning for energy stocks like Chevron (CVX) and ExxonMobil (XOM). These stocks are up nearly 6% and 7% respectively in the past week, and they’re up marginally today as well. This [...]

210, 2024

Nike Falls 6% on Dwindling Sales and Profits in Q1 With Weak Guidance for Q2: Is it Time to Sell NKE?

By |October 2nd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Nike Inc. (NKE) is down roughly 6% Wednesday morning after the company’s earnings day Tuesday left much to be desired in the eyes of investors.  The company is still struggling to regain its footing, and after withdrawing its full-year guidance, it’s clear that the road ahead will continue to be rocky. Here’s how the footwear brand performed in the [...]

110, 2024

Stellantis Shares Fall Amidst Forecast Cuts: While it May Be Time for Investors to Sell STLA

By |October 1st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Stellantis NV (STLA) are down 11% in the past week as the Netherlands-based automaker was forced to lower its full-year forecast as costs are climbing while production is falling. The company was originally expecting to deliver a double-digit profit percentage for the fiscal year, but now, the profit guidance has been brought down to just 5.5% to [...]

3009, 2024

Bristol Myer Stock Gets a Bump on FDA Approval for Schizophrenia Drug: Is it Time to Buy BMY?

By |September 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Late last week Bristol Myers Squibb (BMY) got a nice 8% boost after sharing news that it gained approval from the Food and Drug Administration (FDA) for its schizophrenia drug.  The stock has cooled off since and is up just shy of 4% over the past week, but it has been on a serious tear over the past few [...]

3009, 2024

Weekly Market Recap: Major Indices Manage Gains Amid Economic Data Releases

By |September 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , , , |

Monday: The Major Indices started the week in positive territory with investors keeping an eye on the upcoming Personal Consumption Expenditures report. The Dow rose 0.2%, the S&P 500 gained 0.3%, and the Nasdaq added 0.1%. Tuesday: China's new stimulus plan helped boost sentiment despite lower-than-expected housing data, leading to another day of gains. The Dow increased 0.2%, the [...]

3009, 2024

Investors’ Inspiration

By |September 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News, VectorVest|Tags: , , , , , , |

Written by: Angela Akers In last week’s “Special Presentation,” Mr. Steve Chappell discussed and demonstrated the efficacy and effectiveness of the VectorVest RealTime Derby. The Derby analyzes, sorts, ranks and graphs the second-by-second performance of 169 portfolios. It tracks each portfolio’s performance from the current day’s opening bell and displays the results from the previous day’s close or the [...]

Analyze Any Stock Free

30-DAY TRIAL

  • FREE MOBILE APP
  • FREE COACHING
  • FREE QUICK START COURSE
Ready to test-drive VectorVest? Sign up now and
try a simpler approach to picking the right stocks.
Go to Top